BATB Financaial Analysis
BATB Financaial Analysis
BATB Financaial Analysis
Submitted to:
Najifa Teesha
Lecturer on Principal of Finance
BBA Program Southeast University
Submitted By:
ID :
Section :
FINANCIAL ANALYSIS OF: BRITISH AMERICAN
TOBACCO BANGALDESH LIMITED
Table of Contents
List of Tables ................................................................................................................................................. v
List of Figures ................................................................................................................................................ v
....................................................................................................................................... 1
CHAPTER 1: INTRODUCTION ..................................................................................................................... 2
1.1 Introduction to the study ................................................................................................................... 3
1.2 Significance of the Study .................................................................................................................... 3
1.3 Literature Review ............................................................................................................................... 3
1.4 Limitation of the Study ...................................................................................................................... 4
1.5 Methodology ...................................................................................................................................... 5
Chapter 2: Organizational Overview ........................................................................................................... 6
2.1 Introduction to British American Tobacco Group ............................................................................. 7
2.2 Introduction to British American Tobacco Bangladesh .................................................................... 8
Chapter 3: Job Description ......................................................................................................................... 10
3.1 Responsibilities ................................................................................................................................. 11
3.2 Limitations for the Study ................................................................................................................. 11
Chapter 4: Report Overview ....................................................................................................................... 12
4.1 Common Size Financial Statements ................................................................................................. 13
4.2 Ratio Analysis ................................................................................................................................... 13
4.3 Risk and Return ................................................................................................................................ 14
4.4 Weighted Average Cost of Capital ................................................................................................... 14
4.5 Stock Valuation ................................................................................................................................ 14
Non-Constant Dividend Model ........................................................................................................... 14
Corporation Valuation Model ............................................................................................................. 15
Chapter 5: COMMON SIZE STATEMENTS ................................................................................................... 16
5.1 Vertical Balance Sheet ..................................................................................................................... 17
5.2 Vertical Income Statement .............................................................................................................. 18
5.3 Horizontal Balance Sheet ................................................................................................................. 20
5.4 Horizontal Income Statement .......................................................................................................... 21
Chapter 6: RATIO ANALYSIS ....................................................................................................................... 22
6.1 Liquidity Ratio...................................................................................................................................
23 Exe cutive Summary iv
6.2 Asset Management Ratios ............................................................................................................... 25
6.3 Debt Management Ratio .................................................................................................................. 29
6.4 Profitability Ratio ............................................................................................................................. 31
6.5 Stock Market Ratio ........................................................................................................................... 36
6.6 Overall Findings and Recommendations ......................................................................................... 38
Chapter 7: RISK AND RETURN .................................................................................................................... 39
7.1 Returns of BATBC ............................................................................................................................. 40
7.2 Returns of DSE INDEX ...................................................................................................................... 41
7.3 CAPM Model and Required Rate of Return..................................................................................... 43
7.4 Risk Analysis ..................................................................................................................................... 43
Continued of Content
List of Tables
Table 1: Vertical Statement of Financial
Position ....................................................................................... 18
Table 2: Vertical Statement of Profit or Loss and Other Comprehensive
Income ...................................... 19
Table 3: Horizontal Statement of Financial
Position ................................................................................... 21
Table 4: Horizontal Statement of Profit or Loss and Other Comprehensive
Income ................................. 21
Table 5: Liquidity
Ratio........................................................................................................................... 23
Table 6: Asset Management
Ratio .............................................................................................................. 26
Table 7: Debt Management
Ratio ............................................................................................................... 29
Table 8: Profitability
Ratio .......................................................................................................................... 32
Table 9: Stock Market
Ratio ........................................................................................................................ 36
Table 10: Returns of British American Tobacco
Bangladesh ...................................................................... 40
Table 11: Returns of DSE
Index ................................................................................................................... 41
Table 12: Weighted Average Cost of
Capital………………………………………………………………………………………….4
5
Table 13: Dividend per
Share ...................................................................................................................... 47
Table 14: Growth
Rate ................................................................................................................................ 47
Table 15: Future
Dividend ........................................................................................................................... 47
Table 16: Present Value of Future
Dividend ............................................................................................... 47
Table 17: Free Cash Flow and Growth
Rate ................................................................................................ 48
Table 18: Future Free Cash
Flows ............................................................................................................... 49
Table 19: Present Value of Future Free Cash
Flows.................................................................................... 49
Table 20: Value of per Common
Share ....................................................................................................... 49
List of Figures
Figure 1: Current
Ratio ................................................................................................................................ 24
Figure 2: Acid Test Ratio/ Quick
Ratio ........................................................................................................ 24
Figure 3: Inventory Turnover
Ratio ............................................................................................................. 26
Figure 4: Total Assets Turnover
Ratio ......................................................................................................... 27
Figure 5: Fixed Assets Turnover
Ratio ......................................................................................................... 27
Figure 6: Day's Sales
Outstanding ............................................................................................................... 28
Figure 7: Average Payment
Period.............................................................................................................. 28
Figure 8: Debt
Ratio .................................................................................................................................... 30
Figure 9: Times Interest
Earned .................................................................................................................. 30
Figure 10: Gross Profit
Margin .................................................................................................................... 33
Figure 11: Net Profit
Margin ....................................................................................................................... 33
Figure 12: Operating Profit
Margin ............................................................................................................. 34
Figure 13: Return on
Assets ........................................................................................................................ 34
Figure 14: Return on
Equity ........................................................................................................................ 35
Figure 15: Earnings per
Share ..................................................................................................................... 37
Figure 16: Price Earnings
Ratio ................................................................................................................... 37
Figure 17: Regression
Analysis .................................................................................................................... 42
Figure 18: Scatter Diagram of BATB ................................................................. 42 1
Executive Summary
• The report provides the background and the financial position of the BRITISH
AMERICAN TOBACCO BANGLADESH. At first, I have started with introduction
where I discussed about background of the organization, its product portfolio.
Moreover, I have done analysis on the common size statement of BATB; it is mainly the
vertical and horizontal balance sheet and income statement. After that I have focused on
ratio analysis. I have done ratio analysis of BATB of last 5 years from 2012 to 2016. In
calculating the ratio analysis, I have used the information of balance sheet and income
statement from the annual report of those years. In ratio analysis I have interpreted only
time series analysis. Furthermore, I have analyzed the risk and return of the company.
Here I have used the information about the company’s price of the stock, the market
price of the stock and the risk free rate. After that I have also discussed and analyzed the
cost of capital. The main part of the cost of capital was calculating the WACC. In
addition, I have analyzed the value of common stock by using non-constant dividend
growth model and corporation stock valuation model. I have also included a brief
description about the ongoing project for which I was recruited. Lastly, in the appendix
part I have given the formulas and equations with which I have done the whole analysis.
2
CHAPTER 1: INTRODUCTION
1.1 Introduction to the study
British American Tobacco Bangladesh is one of the biggest MNC as well as
company in Bangladesh. It is well known for selling best quality cigarettes and
covering maximum share among the smokers in our country. But as cigarettes is a
controversial product, BATB has to maintain a lot of strict rules and regulations
from paying the highest tax to the government for conducting massive CSR
Activities to maintain its Corporate Image.
My report consists of a rigorous financial analysis of British American Tobacco
across five year from 2012 to 2016 to determine how they have performed through
the years and to forecast how they might perform in the future. The report also
determines what may be the value of the organization through the price of their
share or stock.
1.2 Significance of the Study
My research will help an individual understand:
Ø How BATB have significantly been able to improve their Net Turnover and Net
Profit across the years
Ø How they have performed in terms of liquidity, asset management, debt
management, profitability and stock market
Ø How much risk they are able to take and how much return they expect to
receive for it
Ø What is the structure of BATB’s capital and the cost of it
Ø What could be the future value of BATB’s stock
1.3 Literature Review
Financial analysis is an aspect of the overall business finance function that
involves examining historical data to gain information about the current and future
financial health of a company. Financial analysis can be applied in a wide variety
of situations to give business managers the information they need to make critical
decisions. The ability to understand financial data is 4
1.1 Introduction to the study
The presence of British American Tobacco in this part of the world can be traced
back to 1910. Beginning the journey as Imperial Tobacco 106 years ago, the
Company set up its first sales depot at Armanitola in Dhaka. After the partition of
India in 1947, Pakistan Tobacco Company was established in 1949. The first
factory in Bangladesh (the then East Pakistan) was set up in 1949 in Fauzdarhat,
Chittagong. In 1965, the second factory of Pakistan Tobacco Company went into
production in Mohakhali, Dhaka. It became Bangladesh Tobacco Company
Limited in 1972 immediately after Bangladesh's independence. In 1998, the
Company changed its name and identity to British American Tobacco Bangladesh
(BAT Bangladesh or BATB) aligning the corporate identity with other operating
companies in the British American Tobacco Group. BAT Bangladesh is a part of
BAT plc, world's leading tobacco group, with brands sold in 200 markets around
the world. We make high quality tobacco products for the diverse preferences of
consumers, spanning the business 'from crop to consumer', and we are committed
to embedding the principles of corporate social responsibility through our
responsible business operation.
Vision
World’s best at satisfying consumer moments in tobacco and beyond.
Mission
Delivering our commitments to society, while championing informed consumer
choice.
Our Shareholders
We were among the first companies to be listed on the Dhaka and Chittagong
Stock Exchanges and currently rank 3rd in terms of market capitalization. British
American Tobacco Group holds 9
Our Contributions
2019 2018
Particular Notes
BDT (000) BDT (000)
Assets
Non-current assets
Property, plant and equipment 8 (a) 29,531,965 26,483,587
2019 2018
Notes
BDT (000) BDT (000)
Gross revenue 269,854,574 233,118,187
Supplementary duty and VAT (213,033,244) (178,478,420)
Net revenue from contracts with customers 23 56,821,330 54,639,767
Cost of sales 24 (29,972,780) (27,096,297)
Gross profit 26,848,550 27,543,470
Operating expenses 25 (8,081,557) (6,723,690)
Operating profit 18,766,993 20,819,780
Net finance income/(expenses) 26 (471,367) (473,916)
Non-operating income/(expenses) 27 24,296 (14,996)
Profit before contribution to WPPF 18,319,923 20,330,867
Contribution to WPPF (915,996) (1,016,543)
Profit before tax 17,403,927 19,314,324
Income tax expense
Current tax 28 (7,028,523) (8,985,069)
Deferred tax 29 (1,129,055) (317,221)
(8,157,578) (9,302,290)
Profit for the year 9,246,349 10,012,034
Other comprehensive income
Other comprehensive income that will not be reclassified to profit or loss
in subsequent periods (net of tax):
Remeasurement on defined benefit plans 30 34,766 (35,430)
Deferred tax impact on defined benefit plans 30 (16,514) 39,811
Other comprehensive loss for the year, net of tax 18,252 4,382
Total comprehensive income for the year, net of tax 9,264,601 10,016,416
BDT BDT
Earnings per share 31 51.37 55.62
31
2019 2018
BDT (000) BDT (000)
Operating activities
Collection from distributors, leaf export and others 271,431,599 231,202,535
Payment for costs and expenses (38,440,015) (36,613,162)
Supplementary duty and VAT paid (208,171,085) (176,779,610)
Cash generated from operating activities 24,820,499 17,809,762
Income tax paid (8,924,585) (8,430,769)
Interest paid (306,674) (453,734)
Net cash flows from operating activities 15,589,240 8,925,259
Investing activities
Purchase of property, plant and equipment (3,215,508) (6,978,665)
Proceeds from sale of property, plant and equipment 29,548 100,836
Net cash flows used in investing activities (3,185,959) (6,877,829)
Financing activities
Proceeds from short term loan 15,880,000 9,800,000
Repayment of short term loan (20,260,000) (5,420,000)
Payment of lease liabilities (479,691) -
Dividend paid (2,996,565) (3,596,316)
Net cash flows used in financing activities (7,856,256) 783,684
Net Increase/(decrease) in cash and cash equivalents 4,547,025 2,831,114
Cash and cash equivalents at 01 January* 833,725 (2,079,741)
Effect of exchange rate fluctuations on cash held 13,013 82,351
Cash and cash equivalents at 31 December* 5,393,764 833,725
*Cash and cash equivalents include bank overdrafts that are payable on demand and form an integral part of the Company's cash
management.
(iii) Depreciation
All items of property, plant and equipment have been depreciated on straight line basis. Depreciation on additions are
charged from the month of acquisition. On disposal of an asset, depreciation is charged up to the month prior to the
disposal. No depreciation is charged for land and assets under construction. The Company is following this policy
consistently from past years.
The estimated useful lives and the rates of residual value of property, plant and equipment for the current and comparative
years are as follows:
Depreciation method, useful lives and residual values are reviewed at each reporting date and adjusted as appropriate. No
significant adjustment in respect of items of property, plant and equipment was done in the twelve-month period ended 31
December 2019.
Assets under construction represent the cost incurred for acquisition and/or construction of items of property, plant and
equipment that are not ready for use at reporting date and these are stated at cost, net of accumulated impairment losses, if
any.
(v) Impairment
The carrying amount of the entity’s non-financial assets, other than inventories and deferred tax assets (considered as disclosed
separately under respective accounting standards), are reviewed at each reporting date to determine whether there is any
indication of impairment. If any such indication exists, the assets’ recoverable amounts are estimated. However, no such
conditions that might be suggestive of a heightened risk of impairment of assets existed at the reporting date.
An impairment loss is recognised through the statement of comprehensive income whenever the carrying amount of an
asset exceeds its recoverable amount.
The recoverable amount of an asset is calculated as the present value of estimated future cash flows, that will be
generated by the use of that asset, discounted at an appropriate rate.
An asset is derecognised on disposal or when no further economic benefits are expected from its use. Gain or loss on
disposal of an asset is determined as the difference of net disposal proceeds and the carrying amount of the asset and is
recognised as gain or loss from disposal of asset under other income/expense in the statement of profit or loss and other
comprehensive income.
Amounts without
As reported Adjustment
Notes adoption of IFRS 16
BDT (000) BDT (000) BDT (000)
Assets
Non-current assets
Property, plant and equipment 29,531,965 - 29,531,965
Right of use of assets 8.b (ii) 1,672,223 (1,672,223) -
Total non-current assets 31,204,188 (1,672,223) 29,531,965
Current assets
Inventories 16,537,884 - 16,537,884
Trade and other receivables 2,609,916 - 2,609,916
Advances, deposits and prepayments 3,684,485 - 3,684,485
Cash and cash equivalents 5,393,764 - 5,393,764
Total current assets 28,226,049 - 28,226,049
Total assets 59,430,237 (1,672,223) 57,758,014
Equity and liabilities
Equity
Share capital 1,800,000 - 1,800,000
Capital reserve 64,896 - 64,896
Retained earnings 33,928,559 65,925 33,994,484
Total equity attributable to owners of 35,793,455 65,925 35,859,380
the Company
Non-current liabilities
Net defined benefit plans 951,616 - 951,616
Deferred tax 17.1 4,258,548 62,091 4,320,639
Lease liabilities 8.b (ii) 1,412,243 (1,412,243) -
Total non-current liabilities 6,622,407 (1,350,152) 5,272,255
Current liabilities
Bank overdrafts - - -
Short term bank loans - - -
Trade and other payables 12,237,053 2,701 12,239,754
Lease liabilities 390,698 (390,698) -
Current tax liabilities 4,022,936 - 4,022,936
Provisions 363,688 - 363,688
Total current liabilities 17,014,375 (387,997 ) 16,626,378
Total liabilities 23,636,782 (1,738,149) 21,898,633
Total equity and liabilities 59,430,237 (1,672,224) 57,758,014
Impact on the statement of profit or
loss and other comprehensive income
For the year ended 31 December 2019
Amounts without
As reported Adjustment
Notes adoption of IFRS 16
BDT (000) BDT (000) BDT (000)
Gross revenue 269,854,574 - 269,854,574
Supplementary duty and VAT (213,033,244) - (213,033,244)
Net revenue from contracts with 56,821,330 - 56,821,330
customers
Amounts without
As reported Adjustment
adoption of IFRS 16
BDT (000) BDT (000) BDT (000)
Operating activities
Collection from distributors, leaf export and others 271,431,599 - 271,431,599
Payment for costs and expenses (38,440,015) (524,440) (38,964,455)
Supplementary duty and VAT paid (208,171,085) - (208,171,085)
Cash generated from operating activities 24,820,499 (524,440) 24,296,059
Investing activities
Purchase of property, plant and equipment (3,215,508) - (3,215,508)
Proceeds from sale of property, plant and 74,298 - 74,298
equipment
Net cash flows used in investing activities (3,141,210) - (3,141,210)
Financing activities
Proceeds from short term loan 15,880,000
Repayment of short term loan (20,260,000) 15,880,000
Payment of lease liabilities (524,440) 524,440 (20,260,000)
Dividend paid (2,996,565) (2,996,565)
Net cash flows used in financing activities (7,901,005) 524,440 (7,376,565)
Assets
Non-current assets
Equity
The notes on pages 217 to 259 are an integral part of these financial statements
2018 2017
Notes
BDT (000) BDT (000)
(9,302,290) (8,929,663)
Total comprehensive income for the year, net of tax 10,016,416 7,829,856
BDT BDT
Balance
at 01 January 2017 600,000 64,896 18,217,686 18,882,582
Balance
at 31 December 2017 600,000 64,896 22,447,542 23,112,438
The notes on pages 217 to 259 are an integral part of these financial statements.
BRITISH AMERICAN TOBACCO BANGLADESH
COMPANY LIMITED
Statement of cash flows
For the year ended 31 December 2018
2018 2017
BDT
BDT (000) (000)
Operating activities
Investing activities
Financing activities
*Cash and cash equivalents include bank overdrafts that are payable on demand and form an integral part of the
Company’s cash management.
The notes on pages 217 to 259 are an integral part of these financial statements.
Chapter 7:
RISK AND RETURN
7.1 Returns of BATBC
For Years of 2015-2016
2015 2016
January
10.2743% 9.1488%
February
4.3509% -7.1677%
March
2.6269% -4.9993%
April
0.3969% 1.9485%
May
-7.4915% -2.7852%
June
3.5081% 0.9233%
July
0.9864% -1.2822%
August
2.7057% -7.0473%
September
1.0266% 2.8288%
October
-0.4465% 0.7379%
November
-1.1146% -0.3337%
December
1.0411% -2.6465%
Expected Return 2.87%
Standard Deviation (risk) 7.57%
Expected Annual Return (Percentage) 34.48%
CV 2.64
Table 10: Returns of British American Tobacco Bangladesh
2015 2016
January
-4.4008% -1.7977%
February
2.3257% -1.0626%
March
-4.4132% -2.8211%
April
-10.3215% -4.1910%
May
15.8398% 5.9449%
June
-0.8764% 1.9401%
July
4.8052% 0.6709%
August
-0.6946% -0.1573%
September
2.7000% 3.2127%
October
-6.0218% -2.1052%
November
1.4651% 4.4461%
December
0.1724% 4.4169%
CV 10.36
Table 11: Returns of DSE Index
Source: Bangladesh Bank official website (cut off yield, August, 2017)
We have considered the monthly T-bill’s cut off yield as the risk free rate because Government
Treasury Bills are risk free short term debt.
Ҡe = Rf+ (Rm-Rf) β
=4.163%
BATBC has no Bank Loans or bonds. They only consist of Common Stock and Retained
Earnings. So it can be said that BATBC’s capital structure has no debt but only consists of
equity. Common Stock taking by 3.19% and Retained Earning taking up to 96.81%.
Wcs= 3.19%
Wre= 96.81%
Ke= 4.16%
45
Chapter 9:
STOCK VALUATION
9.1 Non-constant Dividend Growth Model
g1= 6.54%
g2= 24.01%
g3= -27.54%
g4= 22.57%
Average growth rate 6.40%
Table 14: Growth Rate
Dividend Calculation:
PVFCF2017 7503870.84
PVFCF2018 8577046.19
PVFCF2019 9803703.04
The project had started from 2016 and now under pilot launch in many parts of the country. The
pilot launches has brought up positive results and steps are taken to make improvements in areas
where required. The project will be put into full force by 2019. It is of great regret that due to
confidential reasons, the financial results that show this project will bring about great
improvement in the company as a whole cannot be presented.
As a result, only the financial information available to the public at large has been used for the
financial analysis of the organization. From the analysis part of this report, we can get a clear
idea that BATB has a few areas where improvement is required. With the help and
implementation of this project hopefully BATB can perform at their best.
Reference
British American Tobacco Bangladesh 2012- ―British American Tobacco Bangladesh Annual
Report 2012‖
British American Tobacco Bangladesh 2013- ―British American Tobacco Bangladesh Annual
Report 2013‖
British American Tobacco Bangladesh 2014- ―British American Tobacco Bangladesh Annual
Report 2014‖
British American Tobacco Bangladesh 2015- ―British American Tobacco Bangladesh Annual
Report 2015‖
British American Tobacco Bangladesh 2016- ―British American Tobacco Bangladesh Annual
Report 2016‖
Keown, A. J., Martin, J. D., Petty, J.W., Scott, D. F. (2013-2014) Financial Management:
Principles and Applications, Tenth Edition
Equity
Share Capital 600,000 600,000
Capital Reserve 64,896 64,896
Retained Earnings 18,217,686 13,944,623
Total equity attributable to owners of the
company 18,882,582 14,609,519
Liabilities
Gratuity
Net defined benefit plans 800,663 461,230
Deferred tax liabilities 2,027,373 2,069,796
Obligation under finance lease (due within
one year)
Non-current liabilities 2,828,036 2,531,026
54
British American Tobacco Bangladesh Company Limited
Statement of Profit or Loss and Other Comprehensive Income
Year 2016 2015
Gross turnover 165,633,760 143,711,664
Supplementary duty & VAT (121,879,985) (103,816,770)
Net turnover 43,753,775 39,894,894
Cost of Sales (23,890,895) (21,212,511)
Gross profit 19,862,880 18,682,383
Operating expenses (5,936,146) (5,481,856)
Operating profit 13,926,734 13,200,527
Net financial Income/ (expenses) (36,468) (122,828)
Non-operating Income/ (expenses) (26,708) 37,680
Profit before contribution to WPPF 13,863,558 13,115,379
Contribution to WPPF (693,178) (655,767)
Profit before tax 13,170,380 12,459,612
Income tax expense
Current Tax (5,622,651) (5,633,340)
Deferred Tax 34,733 (952,198)
(5,587,918) (6,585,538)
Net Profit for the Year 7,582,462 5,874,074
Actuarial revaluation for employee
benefit
Deferred tax arising from actuarial
revaluation
Other comprehensive income (9,399) (28,066)
Total comprehensive income 7,573,063 5,846,008
Earnings Per Share (BDT) 126.37 97.90
Vertical Statement of Financial Position
Assets
Gratuity
165633760 143711664
Gross turnover
165633760 143711664
Supplementary duty & -121879985 -103816770
VAT 165633760 143711664
43753775 39894894
Net turnover
165633760 143711664
-23890895 -21212511
Cost of Sales
165633760 143711664
19862880 18682383
Gross profit
165633760 143711664
-5936146 -5481856
Operating expenses
165633760 143711664
13926734 13200527
Operating profit
165633760 143711664
Net financial Income/ -36468 -122828
(expenses) 165633760 143711664
Non-operating -26708 37680
Income/ (expenses) 165633760 143711664
Profit before 13863558 13115379
contribution to WPPF 165633760 143711664
-693178 -655767
Contribution to WPPF
165633760 143711664
13170380 12459612
Profit before tax
165633760 143711664
Income tax expense
-5622651 -5633340
Current Tax
165633760 143711664
34733 -952198
Deferred Tax
165633760 143711664
-5587918 -6585538
165633760 143711664
7582462 5874074
Net Profit for the Year
165633760 143711664
Actuarial revaluation
for employee benefit
Deferred tax arising
from actuarial
revaluation
Other comprehensive -9399 -28066 -55478
income 165633760 143711664 109581710
Total comprehensive 7573063 5846008 6281922 4868649 3941640
income 165633760 143711664 126725499 109581710 90174080
13979180 8553377
Inventories
4956887 4956887
1062450 940758
Trade and Other Receivables
937873 937873
Advance, deposit and pre- 3329480 4074679
payments 999016 999016
1564600 2357002
Cash and Cash Equivalent
2279090 2279090
19935710 15925816
Current Assets
9172866 9172866
35347583 29590831
Total Assets
15034493 15034493
Equity
600000 600000
Share Capital
600000 600000
64896 64896
Capital Reserve
64896 64896
18217686 13944623
Retained Earnings
6368044 6368044
Total equity attributable to owners 18882582 14609519
of the company 7032940 7032940
Liabilities
Gratuity
240592 240592 240592
Net defined benefit plans
2027373 2069796 1140562 883376 723643
Deferred tax liabilities
723643 723643 723643 723643 723643
Obligation under finance lease 7541
(due within one year) 7541
2828036 2531026 1508672 1247439 971776
Non-current liabilities
971776 971776 971776 971776 971776
Bank overdraft
Short term bank loans
2338056 2188035
Provision for Expenses
2188035 2188035
8218406 7842726 7152166 3701889 3245676
Trade and other payables
3245676 3245676 3245676 3245676 3245676
2499269 3500379 2729914 2267283 1585731
Current tax liabilities
1585731 1585731 1585731 1585731 1585731
Provisions and accruals
Obligation under finance lease 7541 10335
(due within one year) 10335 10335
13636965 12450286 14102836 8314769 7029777
Current liabilities
7029777 7029777 7029777 7029777 7029777
16465001 14981312 15611508 9,562,208 8,001,553
Total liabilities
8,001,553 8,001,553 8,001,553 8,001,553 8,001,553
35347583 29590831 27075019 18463798 15034493
Total equity and liabilities
15034493 15034493 15034493 15034493 15034493
2013
2014
2015
2016
940758 7842726
2015
16940236/3
60
2016
62
Debt Management Ratio:
1 553
2012 1
15 344 3
9504368
2013 *100
88796
11535203
2014 *100
187965
2015 *100
2016
Profitability Ratio
Return
Gross Profit Net Profit Operating on
Year Return On Equity
Margin Margin Profit Margin Assets
2012
*100
2013 *100 *100 *100
*100
63
2014
*100
2016
2015
2016
EXPECTED RETURN CALCULATION:
WACC CALCULATION:
Growth Calculation
g1= =(49.96-46.89)/ 46.89
g2= =(61.96-49.96)/ 49.96
g3= =(44.90-61.96)/ 61.96
g4= =(55.03-44.90)/ 44.90
Dividend Calculation:
PV2016
Div2017= = 58.55/(0.04163+1)
PV2017
Div2018= = =62.3/(1+0.04163)^2
PV2018
Div2019= = =66.29/(1+0.04163)^3
15,925,816- 19,935,710-
Working capital
12,450,286 13,636,965
1-(7,582,462
1-(5,874,074/
12,459,612)
Depreciation
961,076 1,262,062
Expense:
Initial Spending 0 0
13,200,527+142,5 13,926,734
EBIT: 61 +187,965
14,114,699(
13,343,088(1- 1-
FCF 52.86%)+961,076- 42.43%)+1,2
3,475,530-0 62,062-
6,298,745-0
(6564973.11
(4729741.05- -
543.96 /4729741.0
PVFCF2017 7816256.99/(1+0.04163)
PVFCF2018 9306035.57/(1+0.04163)^2
PVFCF2019 11079765.95/(1+0.04163)^3
PV of Terminal
value 1729646720/(1+0.04163)^3
Value of Per
Common Share 1556326949.70/60,000,000